Efficient and Simultaneous LC‐MS/MS Detection of N‐Nitroso and Di‐Nitroso Leucovorin in Leucovorin Drug Products: Method Development and Validation
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1867014504650375168 |
|---|---|
| author | Jaya Yalamanchili Himavathi Ganja Suresh Salakolusu |
| author_facet | Jaya Yalamanchili Himavathi Ganja Suresh Salakolusu Jaya Yalamanchili Himavathi Ganja Suresh Salakolusu |
| collection | Wiley Open Access |
| contents | Efficient and Simultaneous LC‐MS/MS Detection of N‐Nitroso and Di‐Nitroso Leucovorin in Leucovorin Drug Products: Method Development and Validation Jaya Yalamanchili Himavathi Ganja Suresh Salakolusu Rapid Communications in Mass Spectrometry ABSTRACT Rationale The occurrence of complex nitrosamines, namely, N‐nitroso drug substance related impurities (NDRSI) in pharmaceuticals is of great concern due to their potential carcinogenic and mutagenic properties. This creates the need for more rigid and more specific methods of analysis to determine NDSRI levels in pharmaceutical products. The main analysis problem is that it is difficult to separate these impurities and the active pharmaceutical ingredient by chromatography, which is due to their structural similarity. This study describes how a new method of measuring two specific impurities in the Leucovorin drug product, N‐nitroso leucovorin and di‐nitroso leucovorin, was developed and validated. Methods Quantification was done by selective reaction monitoring by a positive electrospray ionization source. The required separation was achieved with the use of a reverse‐phase C‐8 column and gradient‐elution in the methanol and water solutions, both adjusted with 0.1% formic acid. Results Linearity of the method was established in a range of 0.1 to 1.5 ng/mL, which is effectually 10% to 150% of its necessary regulatory limit. The procedure had a detection limit of 0.05 ng/mL and a quantitation limit of 0.1 ng/mL. Additionally, it also demonstrated excellent specificity, precision, linearity, accuracy, and robustness when dealing with the two impurities. Conclusions This methodology will therefore offer a crucial solution to drug manufacturers to track and control N‐nitroso leucovorin and Di‐nitroso leucovorin concentrations, which will have a positive impact on regulatory compliance and patient safety. 10.1002/rcm.70049 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| doi_str_mv | 10.1002/rcm.70049 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_rcm_70049 |
| institution | Wiley Open Access |
| license_str_mv | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| publishDate | 2026 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Efficient and Simultaneous LC‐MS/MS Detection of N‐Nitroso and Di‐Nitroso Leucovorin in Leucovorin Drug Products: Method Development and Validation Jaya Yalamanchili Himavathi Ganja Suresh Salakolusu Rapid Communications in Mass Spectrometry Efficient and Simultaneous LC‐MS/MS Detection of N‐Nitroso and Di‐Nitroso Leucovorin in Leucovorin Drug Products: Method Development and Validation Jaya Yalamanchili Himavathi Ganja Suresh Salakolusu Rapid Communications in Mass Spectrometry ABSTRACT Rationale The occurrence of complex nitrosamines, namely, N‐nitroso drug substance related impurities (NDRSI) in pharmaceuticals is of great concern due to their potential carcinogenic and mutagenic properties. This creates the need for more rigid and more specific methods of analysis to determine NDSRI levels in pharmaceutical products. The main analysis problem is that it is difficult to separate these impurities and the active pharmaceutical ingredient by chromatography, which is due to their structural similarity. This study describes how a new method of measuring two specific impurities in the Leucovorin drug product, N‐nitroso leucovorin and di‐nitroso leucovorin, was developed and validated. Methods Quantification was done by selective reaction monitoring by a positive electrospray ionization source. The required separation was achieved with the use of a reverse‐phase C‐8 column and gradient‐elution in the methanol and water solutions, both adjusted with 0.1% formic acid. Results Linearity of the method was established in a range of 0.1 to 1.5 ng/mL, which is effectually 10% to 150% of its necessary regulatory limit. The procedure had a detection limit of 0.05 ng/mL and a quantitation limit of 0.1 ng/mL. Additionally, it also demonstrated excellent specificity, precision, linearity, accuracy, and robustness when dealing with the two impurities. Conclusions This methodology will therefore offer a crucial solution to drug manufacturers to track and control N‐nitroso leucovorin and Di‐nitroso leucovorin concentrations, which will have a positive impact on regulatory compliance and patient safety. 10.1002/rcm.70049 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| title | Efficient and Simultaneous LC‐MS/MS Detection of N‐Nitroso and Di‐Nitroso Leucovorin in Leucovorin Drug Products: Method Development and Validation |
| topic | Rapid Communications in Mass Spectrometry |
| url | https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/rcm.70049 |